- Report
- April 2025
- 169 Pages
Global
From €5337EUR$5,850USD£4,561GBP
- Report
- February 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- April 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- March 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- March 2025
- 175 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- February 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- February 2025
- 150 Pages
Global
From €4424EUR$4,850USD£3,782GBP
- Report
- October 2024
- 136 Pages
North America
From €3649EUR$4,000USD£3,119GBP
- Report
- August 2022
- 120 Pages
Global
From €4105EUR$4,500USD£3,509GBP
- Report
- March 2024
- 200 Pages
Global
From €3786EUR$4,150USD£3,236GBP
- Report
- February 2024
- 182 Pages
Global
From €4105EUR$4,500USD£3,509GBP
- Report
- October 2024
- 101 Pages
Global
From €3500EUR$4,110USD£3,096GBP
- Report
- April 2025
- 50 Pages
Global
From €2417EUR$2,650USD£2,066GBP
- Report
- March 2025
- 215 Pages
China
From €3649EUR$4,000USD£3,119GBP
- Report
- March 2025
- 109 Pages
China
From €1642EUR$1,800USD£1,403GBP

Ramipril is a drug used to treat cardiovascular diseases, such as hypertension, congestive heart failure, and myocardial infarction. It is an angiotensin-converting enzyme (ACE) inhibitor, which works by blocking the production of a hormone that causes blood vessels to narrow. This helps to reduce blood pressure and improve blood flow. Ramipril is also used to reduce the risk of stroke, heart attack, and death in people with coronary artery disease. It is available in both generic and brand-name formulations.
Ramipril is a widely used drug in the cardiovascular market, with a long history of safety and efficacy. It is generally well-tolerated and has few side effects. It is also cost-effective, making it an attractive option for many patients.
Some of the companies in the Ramipril market include Pfizer, Novartis, Merck, and Sanofi. Show Less Read more